Production (Stage)
Galectin Therapeutics Inc.
GALT
$1.37
$0.032.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.85% | -44.12% | 5.71% | 8.67% | -8.20% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 80.70% | -36.11% | -4.91% | -11.34% | -6.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -46.18% | -39.82% | 5.05% | 7.18% | -8.12% |
|
|
|||||
| Total Current Assets | -46.18% | -39.82% | 5.05% | 7.18% | -8.12% |
| Net Property, Plant & Equipment | 312.50% | -38.46% | -25.71% | -22.22% | -2.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.03% | -18.93% | -15.92% | -13.51% | -13.29% |
| Total Assets | -45.54% | -39.61% | 4.76% | 6.82% | -8.19% |
|
|
|||||
| Total Accounts Payable | 15.52% | 102.36% | -24.42% | -2.61% | -40.96% |
| Total Accrued Expenses | -16.59% | -29.16% | 6.86% | 23.03% | -3.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 361.20% | 100.34% | 23,877.27% | -8.33% | 4.35% |
| Total Finance Division Other Current Liabilities | -- | 20.33% | 469.84% | -- | -- |
| Total Other Current Liabilities | -- | 20.33% | 469.84% | -- | -- |
| Total Current Liabilities | 213.03% | 40.19% | 72.80% | 15.70% | -19.41% |
|
|
|||||
| Total Current Liabilities | 213.03% | 40.19% | 72.80% | 15.70% | -19.41% |
| Long-Term Debt | -87.14% | -9.49% | 0.66% | 10.77% | 17.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -65.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -97.82% | 22.39% | -- | -- |
| Total Liabilities | 1.02% | -0.73% | 10.61% | 13.23% | 9.65% |
|
|
|||||
| Common Stock & APIC | 0.14% | 0.49% | 0.31% | 0.47% | 0.22% |
| Retained Earnings | -2.39% | -3.09% | -2.97% | -3.40% | -3.24% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -8.73% | -11.18% | -12.25% | -15.09% | -17.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -8.73% | -11.18% | -12.25% | -15.09% | -17.36% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.92% | -11.45% | -12.58% | -15.56% | -18.00% |
|
|
|||||